Cerus Corporation - Common Stock (CERS)
1.4500
-0.0900 (-5.84%)
NASDAQ · Last Trade: Jul 7th, 8:31 PM EDT
Via Benzinga · July 2, 2025
As the regular session of the US market on Wednesday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.
Via Chartmill · July 2, 2025
Via Benzinga · April 2, 2025

Via Benzinga · October 21, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 17, 2024

Via Benzinga · October 16, 2024

Via Benzinga · October 14, 2024

Via Benzinga · August 6, 2024

Via Benzinga · August 2, 2024

Via Benzinga · July 17, 2024

Via Benzinga · July 17, 2024

CERS stock results show that Cerus met analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via InvestorPlace · May 2, 2024

U.S. stock futures were mixed this morning, with the Dow futures falling by around 10 points on Monday.
Via Benzinga · April 8, 2024

Via Benzinga · April 5, 2024

On Wednesday, Cathie Wood-led Ark Invest made a significant move by offloading shares of Block Inc (NYSE:SQ) amidst Bitcoin (CRYPTO: BTC) prices recovering.
Via Benzinga · March 20, 2024

Cerus reports results from the ReCePI Phase 3 trial for INTERCEPT Red Blood Cells, meeting the primary efficacy endpoint in cardiac surgery patients. The safety profile is also favorable. Expect FDA application in 2025.
Via Benzinga · March 19, 2024